Trials / Completed
CompletedNCT00156052
Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer
A Randomized Trial of Hypofractionated Radiotherapy Post-Lumpectomy in Women With Node Negative Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,234 (actual)
- Sponsor
- Ontario Clinical Oncology Group (OCOG) · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To determine if hypofractionated radiotherapy to the whole breast (4,250 cGy/16 fractions over 22 days) is equally effective to standard fractionated radiotherapy (5,000 cGy/25 fractions over 35 days) in women with node negative breast cancer who have undergone lumpectomy. The primary outcome is local breast recurrence and secondary outcomes include morbidity and cost effectiveness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Conventional whole breast radiation schedule | |
| RADIATION | Hypofractionated whole breast radiation schedule |
Timeline
- Start date
- 1993-04-01
- Primary completion
- 2015-06-01
- Completion
- 2015-06-01
- First posted
- 2005-09-12
- Last updated
- 2015-06-08
Locations
11 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00156052. Inclusion in this directory is not an endorsement.